5 completed, 2 unknown, 1 recruiting. 6 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Unknown 2, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Gemcitabine plus Cisplatin: new trials by email Literature Review of Gemcitabine plus Cisplatin trials Research Report on Gemcitabine plus Cisplatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer HAIC, Gemcitabine plus Cisplatin, Adebrelimab - Biliary Tract Cancer | Phase 2 | Recruiting | Air Force Military Medical University, China | 124 | 2025-12-10 | 2026-05-06 |
| Primary Excision Combined With Preoperative Neoadjuvant and Adjuvant Therapy for Oligometastasis of Urothelial Carcinoma primary focal resection plus lymph node dissection, Tislelizumab, Gemcitabine plus cisplatin - Bladder Urothelial Carcinoma | Phase 2 | Completed | The First Affiliated Hospital with Nanjing Medical University | 30 | 2020-12-01 | 2025-08-05 |
| Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma RNU, Gemcitabine/Cisplatin, M-VAC Protocol - Upper Tract Urothelial Carcinoma | Phase 2 | Unknown | The European Uro-Oncology Group | 200 | 2018-05-28 | 2023-12-18 |
| Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma Gemcitabine plus cisplatin, Capecitabine - Cholangiocarcinoma, Biliary Tract Cancer | Phase 2 | Completed | Asan Medical Center | 101 | 2017-05-15 | 2022-12-06 |
| Pemetrexed/Cisplatin Versus Gemcitabine/Cisplatin According to Thymidylate Synthase Expression Gemcitabine plus cisplatin, pemetrexed plus cisplatin - Non-small Cell Lung Cancer | Phase 2 | Unknown | Samsung Medical Center | 304 | 2011-07-01 | 2011-07-25 |
| Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma S-1 plus cisplatin, Gemcitabine plus Cisplatin - Metastatic Biliary Cancer | Phase 2 | Completed | Asan Medical Center | 92 | 2008-03-01 | 2011-12-06 |
| Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer gemcitabine plus cisplatin - Bladder Cancer | Not applicable | Completed | Barmherzige Brüder Vienna | 60 | 2007-04-01 | 2013-03-01 |
| Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC Zactima (ZD6474), Vinorelbine plus cisplatin, Gemcitabine plus cisplatin - Non Small Cell Lung Cancer | Phase 1 | Completed | Genzyme, a Sanofi Company | 17 | 2006-08-01 | 2016-08-26 |
Biliary Tract Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (2) · Cholangiocarcinoma (1) · Urinary Bladder Neoplasms (1)
Asan Medical Center (2) · Air Force Military Medical University, China (1) · Barmherzige Brüder Vienna (1) · Genzyme, a Sanofi Company (1) · Samsung Medical Center (1) · The European Uro-Oncology Group (1) · The First Affiliated Hospital with Nanjing Medical University (1)
South Korea (3) · China (2) · Austria (1) · Netherlands (1) · Norway (1) · Spain (1)
Baek-Yeol Ryoo, MD (1) · Johannes Meran, M.D. (1) · MJ Kang, MD, MSc (1) · Myung-Ju Ahn, M.D., Ph.D. (1) · Qiang Lv (1) · Susanne Osanto, MD, PhD (1)
PMID 22559158, PMID 26124486, PMID 33168398, PMID 39532185, PMID 40803577